Applicant, as named in the Orange Book

Scpharmaceuticals

Next listed expiry: Furoscix on 3 Apr 2034. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Furoscix furosemide	furosemide	209988	3 Apr 2034	patent
Furoscix Readyflow (Autoinjector) furosemide	furosemide	209988	30 Jan 2040	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.